3D Tomosynthesis Decreases Breast Lumpectomy Re-Excisions
|
By MedImaging International staff writers Posted on 05 Oct 2020 |

Image: Vikram Butani and the Mozart 3D specimen tomography system (Photo courtesy of Kubtec)
A new shows that 3D specimen tomosynthesis reduces re-excision rates following breast cancer surgery by more than 50%, when compared with 2D-image guided radiographs.
Researchers at the University of Texas Southwestern Medical Center (UT Southwestern; Dallas, TX, USA) conducted a study that analyzed 657 lumpectomy procedures performed between 2013 and 2018 by four surgeons with access to two dimensional (2D) and three dimensional (3D) radiography in the operating room. The results showed that in the 191 patients whose surgeries were performed using the 3D imaging technology, 5% had to return for a follow-up surgery, compared to an 11% re-excision rate among the 466 patients who underwent 2D imaging during surgery.
For the study, which was published on August 1, 2020, in Annals of Surgical Oncology, the researchers used the Kubtec (Milford, CT, USA) Mozart 3D specimen tomography system, which reconstructs 3D tomographic images from 2D projection images in real-time. The technology offers the ability to examine specimens at varying slice depths, and includes the K-view image for a comprehensive 2D view of individual slices at higher resolution. Physicians can thus view individual 3D slices to identify the exact location of calcifications in breast specimens.
“The use of 3D tomosynthesis specimen radiographs decreased re-excision rates by more than half. This study demonstrated that surgeons can use these techniques without radiologists' interpretation to achieve excellent re-excisions rates,” said lead author Natalia Partain, MD, of the division of surgical oncology. “This allows surgeons to excise additional margins at the index operation, decreasing reoperations and anxiety and costs for patients.”
“Kubtec's Mozart 3D specimen tomosynthesis system can dramatically improve surgeons' efficiency and accuracy and help them provide the best quality of care for their patients,” said Vikram Butani, founder and CEO of Kubtec, commenting on the study results. “A five percent re-excision rate is remarkable, compared with the US average of twenty percent for lumpectomies and eleven percent for surgeries using 2D imaging.”
Tomosynthesis operates based on the same principle as linear tomography, except that the detector can either be mechanically motorized in synchronization with the x-ray source, or simply remain stationary during the specimen exam. By establishing the initial fulcral plane and exposing across the sweep angle, the anatomical details in the fulcral plane are persevered, while anatomical clutter above or below the plane is blurred.
Researchers at the University of Texas Southwestern Medical Center (UT Southwestern; Dallas, TX, USA) conducted a study that analyzed 657 lumpectomy procedures performed between 2013 and 2018 by four surgeons with access to two dimensional (2D) and three dimensional (3D) radiography in the operating room. The results showed that in the 191 patients whose surgeries were performed using the 3D imaging technology, 5% had to return for a follow-up surgery, compared to an 11% re-excision rate among the 466 patients who underwent 2D imaging during surgery.
For the study, which was published on August 1, 2020, in Annals of Surgical Oncology, the researchers used the Kubtec (Milford, CT, USA) Mozart 3D specimen tomography system, which reconstructs 3D tomographic images from 2D projection images in real-time. The technology offers the ability to examine specimens at varying slice depths, and includes the K-view image for a comprehensive 2D view of individual slices at higher resolution. Physicians can thus view individual 3D slices to identify the exact location of calcifications in breast specimens.
“The use of 3D tomosynthesis specimen radiographs decreased re-excision rates by more than half. This study demonstrated that surgeons can use these techniques without radiologists' interpretation to achieve excellent re-excisions rates,” said lead author Natalia Partain, MD, of the division of surgical oncology. “This allows surgeons to excise additional margins at the index operation, decreasing reoperations and anxiety and costs for patients.”
“Kubtec's Mozart 3D specimen tomosynthesis system can dramatically improve surgeons' efficiency and accuracy and help them provide the best quality of care for their patients,” said Vikram Butani, founder and CEO of Kubtec, commenting on the study results. “A five percent re-excision rate is remarkable, compared with the US average of twenty percent for lumpectomies and eleven percent for surgeries using 2D imaging.”
Tomosynthesis operates based on the same principle as linear tomography, except that the detector can either be mechanically motorized in synchronization with the x-ray source, or simply remain stationary during the specimen exam. By establishing the initial fulcral plane and exposing across the sweep angle, the anatomical details in the fulcral plane are persevered, while anatomical clutter above or below the plane is blurred.
Latest General/Advanced Imaging News
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Channels
Radiography
view channel
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read more
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read moreMRI
view channel
Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Many men with suspected prostate cancer face an invasive biopsy when magnetic resonance imaging (MRI) is inconclusive. Biopsies can be uncomfortable, carry risks, and may contribute to overdiagnosis and... Read more
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read moreUltrasound
view channel
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read more
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







